INTERNATIONAL NEUROLOGICAL KETOGENIC SOCIETY

Registered charity 1199462 · accounts filings on the Charity Commission register · also known as INKS

(1) promoting the practice, science, global accessibility and implementation of ketogenic dietary therapies for the treatment of epilepsy and the specific neurometabolic disorder GLUT1 deficiency syndrome;(2) promoting research into ketogenic and metabolic therapies for the treatment of brain disorders(3) educating healthcare professionals about ketogenic and metabolic therapies

Objects

THE ADVANCEMENT OF HEALTH FOR THE PUBLIC BENEFIT BY: (1) PROMOTING THE PRACTICE, SCIENCE, GLOBAL ACCESSIBILITY AND IMPLEMENTATION OF KETOGENIC DIETARY THERAPIES FOR THE TREATMENT OF EPILEPSY AND THE SPECIFIC NEUROMETABOLIC DISORDER GLUT1 DEFICIENCY SYNDROME; (2) PROMOTING RESEARCH INTO KETOGENIC AND METABOLIC THERAPIES FOR THE TREATMENT OF BRAIN DISORDERS AND THE PUBLICATION OF THE USEFUL RESULTS OF SUCH RESEARCH THROUGH COLLABORATION AND EDUCATION; (3) EDUCATING HEALTHCARE PROFESSIONALS ABOUT KETOGENIC AND METABOLIC THERAPIES INCLUDING BY MANAGING AND FACILITATING THE BIENNIAL KETOGENIC THERAPIES GLOBAL SYMPOSIA SERIES.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£30k
Latest spending
£16k
Registered
2022
Accounts read
FY2025

Financial health, per its FY2025 accounts

The charity reported a net incoming resource of £14,007 for the year, increasing its unrestricted funds to £71,888. The trustees consider the financial performance satisfactory and state there are no material uncertainties regarding the charity's ability to continue. Reserves are held at £71,888, significantly above the trustees' stated retention policy target of £20,000.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

Public fundraising profile: JustGiving — INKS (matched by registered charity number).

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Argentina · Australia · China · France · Germany · India · South Africa · South Korea · Throughout England · United States

Income and spending

Financial year endIncomeSpending
30/06/2025£30k£16k
30/06/2024£11k£9k
30/06/2023£67k£11k

Common questions

Is INTERNATIONAL NEUROLOGICAL KETOGENIC SOCIETY financially healthy?

Per its FY2025 accounts: The charity reported a net incoming resource of £14,007 for the year, increasing its unrestricted funds to £71,888. The trustees consider the financial performance satisfactory and state there are no material uncertainties regarding the charity's ability to continue. Reserves are held at £71,888, significantly above the trustees' stated retention policy target of £20,000. Its FY2025 accounts were independently examined.